NCT05258565View on ClinicalTrials.gov

TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

June 15, 2022

Study Completion Date

September 15, 2022

Conditions
Acute Ischemic Stroke
Interventions
DRUG

IV tPA (Activase)

Any patients eligible came with acute ischemic stroke with or without COVID-19 infection within the time window for thrombolytic therapy (within 4 hours of onset)

Trial Locations (2)

Unknown

Aswan University Hospital, Aswān

Assiut University Hospital, Asyut

All Listed Sponsors
collaborator

Aswan University Hospital

OTHER

lead

Assiut University

OTHER